AZYO insider filings

AZIYO BIOLOGICS, INC. — 9 most recent insider filings (SEC Forms 3/4/5) from EDGAR, normalized by FilingPulse. Latest filing: 2023-06-23. Screen AZYO transaction legs live →

Insider transaction summary — last 90 days

No insider filings (Forms 3/4/5) for AZYO between 2026-07-10 and 2026-10-08. The table below lists the most recent filings on record.

Recent insider filings — AZIYO BIOLOGICS, INC.

FiledFormInsiderReported transactionsSource
2023-06-234Mills C Randal — PRESIDENT AND CEO, DirectorOption exercise (M): 22,474 · Tax withholding (F): 7,772 @ $2.41 · Option exercise (M): 22,474 (derivative) @ $0EDGAR
2023-06-124Colpman David — DirectorGrant/award (A): 25,000 (derivative) @ $0EDGAR
2023-06-124Jordan Maybelle — DirectorGrant/award (A): 25,000 (derivative) @ $0EDGAR
2023-06-124Makes Brigid — DirectorGrant/award (A): 25,000 (derivative) @ $0EDGAR
2023-06-124HighCape Capital, L.P. — Director, 10% owner
HIGHCAPE PARTNERS, L.P. — Director, 10% owner
HIGHCAPE PARTNERS QP, L.P. — Director, 10% owner
HighCape Partners GP, LLC — Director, 10% owner
HighCape Partners GP, L.P. — Director, 10% owner
HighCape Co-Investment Vehicle I, LLC — Director, 10% owner
HighCape Co-Investment Vehicle II, LLC — Director, 10% owner
HighCape Capital, LLC — Director, 10% owner
Zuga Matt — Director, 10% owner
RAKIN KEVIN — Director, 10% owner
Grant/award (A): 37,500 (derivative) @ $0 · Grant/award (A): 25,000 (derivative) @ $0EDGAR
2023-04-284Mills C Randal — PRESIDENT AND CEO, DirectorOption exercise (M): 44,947 @ $0 · Grant/award (A): 134,840 (derivative) @ $0 · Option exercise (M): 44,947 (derivative) @ $0 · Grant/award (A): 89,894 (derivative) @ $0EDGAR
2023-03-274Birchview Capital, LP — 10% owner
Birchview Fund LLC — 10% owner
Strobeck Matthew — 10% owner
Purchase (P): 100,000 @ $1.49 · Purchase (P): 10,000 @ $1.49 · Purchase (P): 18,000 @ $1.35 · Purchase (P): 2,000 @ $1.35 · Purchase (P): 10,000 @ $1.59EDGAR
2023-03-094Englese Thomas — CHIEF COMMERCIAL OFFICEROption exercise (M): 937 @ $0 · Sale (S): 289 @ $4.30 · Option exercise (M): 937 (derivative) @ $0EDGAR
2023-03-094Ferguson Matthew — CHIEF FINANCIAL OFFICEROption exercise (M): 1,287 @ $0 · Option exercise (M): 1,287 (derivative) @ $0EDGAR

Recent 8-K events — AZIYO BIOLOGICS, INC.

FiledFormItems reportedSource
2026-08-218-K2.01 — Completion of Acquisition or Disposition of Assets
7.01 — Regulation FD Disclosure
9.01 — Financial Statements and Exhibits
EDGAR
2026-08-138-K2.02 — Results of Operations and Financial Condition
9.01 — Financial Statements and Exhibits
EDGAR
2026-08-078-K3.01 — Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing
9.01 — Financial Statements and Exhibits
EDGAR
2026-07-208-K1.01 — Entry into a Material Definitive Agreement
7.01 — Regulation FD Disclosure
9.01 — Financial Statements and Exhibits
EDGAR
2026-06-168-K5.02 — Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers
5.07 — Submission of Matters to a Vote of Security Holders
9.01 — Financial Statements and Exhibits
EDGAR
2026-05-148-K2.02 — Results of Operations and Financial Condition
9.01 — Financial Statements and Exhibits
EDGAR
2026-03-118-K2.02 — Results of Operations and Financial Condition
9.01 — Financial Statements and Exhibits
EDGAR
2026-03-098-K5.02 — Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers
9.01 — Financial Statements and Exhibits
EDGAR
2026-03-048-K8.01 — Other Events
9.01 — Financial Statements and Exhibits
EDGAR
2026-01-128-K2.02 — Results of Operations and Financial Condition
9.01 — Financial Statements and Exhibits
EDGAR
Need this as JSON? GET https://api.filingpulse.io/v1/insider-trades?ticker=AZYO returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new ones to you in seconds. API docs →